Advocacy intelligence hub — real-time data for patient organizations
Novartis Pharmaceuticals — PHASE3
SYSNAV
BioSensics
Adam Boxer — PHASE2
Adam Boxer — PHASE2
Adam Boxer — PHASE2
Invicro — EARLY_PHASE1
University of Kiel
University of Pennsylvania — EARLY_PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Classic progressive supranuclear palsy syndrome news →
Jennifer Whitwell, PhD
Mayo Clinic
Diana Apetauerova, MD, MD
Lahey Clinic
📍 BURLINGTON, MA
Adam Boxer, MD, PhD, M.D
University of California, San Francisco
📍 SAN FRANCISCO, CA
Frédéric Blanc, MD
Hôpitaux Universitaires Strasbourg
Maria Jose Martí, Md, PhD
Fundació per a la Recerca Biomedica
catherine GEINDRE
Assistance Publique Hopitaux De Marseille
View all Classic progressive supranuclear palsy syndrome specialists →